These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25482819)

  • 1. Escherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection.
    Wang LX; Mellon M; Bowder D; Quinn M; Shea D; Wood C; Xiang SH
    Virology; 2015 Jan; 475():179-86. PubMed ID: 25482819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan.
    Umotoy J; Bagaya BS; Joyce C; Schiffner T; Menis S; Saye-Francisco KL; Biddle T; Mohan S; Vollbrecht T; Kalyuzhniy O; Madzorera S; Kitchin D; Lambson B; Nonyane M; Kilembe W; ; ; Poignard P; Schief WR; Burton DR; Murrell B; Moore PL; Briney B; Sok D; Landais E
    Immunity; 2019 Jul; 51(1):141-154.e6. PubMed ID: 31315032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for germline antibody recognition of HIV-1 immunogens.
    Scharf L; West AP; Sievers SA; Chen C; Jiang S; Gao H; Gray MD; McGuire AT; Scheid JF; Nussenzweig MC; Stamatatos L; Bjorkman PJ
    Elife; 2016 Mar; 5():. PubMed ID: 26997349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Mol Graph Model; 2015 Sep; 61():262-71. PubMed ID: 26298811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.
    Chikaev AN; Bakulina AY; Burdick RC; Karpenko LI; Pathak VK; Ilyichev AA
    PLoS One; 2015; 10(3):e0120847. PubMed ID: 25785734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the reactivity and neutralizing activity of a type-specific neutralizing monoclonal antibody induced by interaction of soluble CD4 with gp120.
    Maeda Y; Matsushita S; Hattori T; Murakami T; Takatsuki K
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2049-54. PubMed ID: 1493053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
    Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
    Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
    Pantophlet R; Wilson IA; Burton DR
    Protein Eng Des Sel; 2004 Oct; 17(10):749-58. PubMed ID: 15542540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F.
    Revilla A; Delgado E; Christian EC; Dalrymple J; Vega Y; Carrera C; González-Galeano M; Ocampo A; de Castro RO; Lezaún MJ; Rodríguez R; Mariño A; Ordóñez P; Cilla G; Cisterna R; Santamaría JM; Prieto S; Rakhmanova A; Vinogradova A; Ríos M; Pérez-Álvarez L; Nájera R; Montefiori DC; Seaman MS; Thomson MM
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):889-901. PubMed ID: 21226626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral resistance to VRC01-like antibodies with mutations in loop D and V5 from an HIV-1 B' subtype infected individual with broadly neutralization activity.
    Zhang D; Liu Z; Wang W; Chen MX; Hou JL; Zhang Z; Ren WH; Ren L; Hao YL
    Mol Immunol; 2022 May; 145():50-58. PubMed ID: 35290812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.
    Martín-García J; Cocklin S; Chaiken IM; González-Scarano F
    J Virol; 2005 Jun; 79(11):6703-13. PubMed ID: 15890908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
    Jiang A; Fisher H; Pomerantz RJ; Dornburg R
    Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
    Sun Z; Li J; Hu X; Shao Y; Zhang MY
    Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
    J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of antibody repertoires to the CD4 binding site of gp120 of a Chinese HIV-1-infected elite neutralizer, using 454 sequencing and single-cell sorting.
    Li D; Wang Z; Ren L; Zhang J; Feng G; Hong K; Hao Y; Qi Z; Liang H; Shao Y
    Arch Virol; 2016 Apr; 161(4):789-99. PubMed ID: 26671829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface.
    Binder U; Matschiner G; Theobald I; Skerra A
    J Mol Biol; 2010 Jul; 400(4):783-802. PubMed ID: 20630471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.